PPP

CTCP Dược phẩm Phong Phú · HNX
18,000 Latest close · 30 Jun 2026 P/E 7.1x P/B 1.1x
Improving positively · Net margin 17.45%, +3.85pp YoY

On a TTM 2026Q1 basis, PPP has not accelerated revenue sharply, but profitability is improving visibly — the growth momentum has held across consecutive periods. Profit growth is driven mainly by better operations rather than scale expansion — a foundation that tends to be more durable.

Revenue TTM
VND 142bn
+0.5%
Net Margin
17.45%
+3.8pp year on year
ROE
17.3%
TTM

Same sector PHARMACEUTICALS